Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TSHA

Taysha Gene Therapies (TSHA)

Taysha Gene Therapies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TSHA
DateTimeSourceHeadlineSymbolCompany
26/09/202422:00GlobeNewswire Inc.Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome CongressNASDAQ:TSHATaysha Gene Therapies Inc
06/09/202422:00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
12/08/202422:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSHATaysha Gene Therapies Inc
12/08/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
12/08/202422:01GlobeNewswire Inc.Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TSHATaysha Gene Therapies Inc
05/08/202422:00GlobeNewswire Inc.Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12NASDAQ:TSHATaysha Gene Therapies Inc
02/08/202422:00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
06/07/202407:51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
06/07/202407:50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
06/07/202407:49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
05/07/202422:00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
26/06/202423:14GlobeNewswire Inc.Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:TSHATaysha Gene Therapies Inc
26/06/202408:34GlobeNewswire Inc.Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:TSHATaysha Gene Therapies Inc
18/06/202421:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
18/06/202421:30GlobeNewswire Inc.Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett SyndromeNASDAQ:TSHATaysha Gene Therapies Inc
07/06/202422:00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
01/06/202406:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSHATaysha Gene Therapies Inc
31/05/202406:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
15/05/202406:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
15/05/202406:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSHATaysha Gene Therapies Inc
15/05/202406:01GlobeNewswire Inc.Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TSHATaysha Gene Therapies Inc
08/05/202406:05GlobeNewswire Inc.Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14NASDAQ:TSHATaysha Gene Therapies Inc
04/05/202406:05GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
02/05/202422:00GlobeNewswire Inc.Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett SyndromeNASDAQ:TSHATaysha Gene Therapies Inc
05/04/202423:00GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
21/03/202404:30AllPennyStocks.comAnother Biotech Steals The Show Following Major Clinical Data ReleaseNASDAQ:TSHATaysha Gene Therapies Inc
20/03/202407:01GlobeNewswire Inc.Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical UpdatesNASDAQ:TSHATaysha Gene Therapies Inc
19/03/202422:27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:TSHATaysha Gene Therapies Inc
15/03/202407:26GlobeNewswire Inc.Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19NASDAQ:TSHATaysha Gene Therapies Inc
02/03/202409:08GlobeNewswire Inc.Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TSHATaysha Gene Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:TSHA